16.06.2024, 1398 Zeichen
CA Immo: The Frankfurt office and hotel tower ONE, developed by CA Immo and designed by Meurer Architektur + Stadtplanung, has now become the first high-rise building in the world to be awarded the DGNB Diamond award by the German Sustainable Building Council (DGNB) for its outstanding architecture and urban integration. The building had previously received the highest certification level of platinum from the DGNB for its exemplary sustainability. The approximately 190-metre-high ONE was opened in autumn 2022 and is almost fully let.
CA Immo: weekly performance:
Immofinanz: Immofinanz has successfully completed the sale of three office buildings in Warsaw to the Polish ECHO Investment Group. The transaction price amounts to EUR 28.5 million. Located in Warsaw’s Mokotów Business District, the office complex has approximately 43,000 sqm of usable space. The sale is in line with the portfolio optimisation strategy of IMMOFINANZ and was carried out at approximately carrying amount. “We are pleased about the successful sale as part of our portfolio optimisation programme and will reinvest the released liquidity in the value-creating expansion of our innovative office and retail solutions,” says Radka Doehring, member of the IMMOFINANZ Executive Board.
Immofinanz: weekly performance:
(From the 21st Austria weekly https://www.boerse-social.com/21staustria (13/06/2024)
Wiener Börse Party #740: Immofinanz / CA Immo Alert für Freitag, Semperit lädt Privatanleger ein, Kontron neu im PIR-Kreis, Spoiler
Aktien auf dem Radar:Immofinanz, Polytec Group, CA Immo, Austriacard Holdings AG, Warimpex, Addiko Bank, voestalpine, RBI, Österreichische Post, Semperit, SBO, Rosenbauer, AT&S, Cleen Energy, EuroTeleSites AG, Porr, Wolford, DO&CO, Wiener Privatbank, Oberbank AG Stamm, BKS Bank Stamm, Agrana, Amag, Erste Group, EVN, Flughafen Wien, OMV, Pierer Mobility, S Immo, Telekom Austria, Uniqa.
Evotec
Evotec ist ein Wirkstoffforschungs- und -entwicklungsunternehmen, das in Forschungsallianzen und Entwicklungspartnerschaften mit Pharma- und Biotechnologieunternehmen, akademischen Einrichtungen, Patientenorganisationen und Risikokapitalgesellschaften Ansätze zur Entwicklung neuer pharmazeutischer Produkte vorantreibt.
>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner
Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab.
Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.
Newsletter abonnieren
Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)
per Newsletter erhalten